Dinesh M G

Led Phase I clinical trials for oncology assets, developed and patented 50 novel small molecules, and secured US FDA Orphan Drug Designation for a new chemical entity. Oversaw research budgets and regulatory submissions to ensure compliance and project success.

Managed global research projects, optimized operations, and led recruitment to enhance team performance. Oversaw research budgets and represented the company at international conferences.

Established a state-of-the-art lab for drug discovery, developed novel oncology molecules, and managed preclinical toxicology studies. Collaborated with QA for regulatory submissions.

Developed protocols for studying insulin resistance and obesity, led in vivo efficacy studies, and managed research teams on DST-funded projects. Authored scientific papers for publication.

Developed methodologies for stem cell differentiation and conducted experiments for wound healing applications. Supervised undergraduate students and ensured compliance with regulatory standards.

Led commercial sampling and managed contract research activities, specializing in cell culture studies. Developed cost-effective research strategies and coordinated with clients.

Developed engineered skin constructs using mesenchymal stem cells to enhance wound healing and tissue regeneration. Conducted extensive research on stem cell differentiation, biomaterials, and regenerative medicine.

Developed comprehensive protocols to study clinical applications in wound repair and insulin resistance. Led in vivo efficacy and toxicity studies using db/db mice and STZ-induced models.

Grade: Distinction

Focused on drug mechanisms of action through in vitro, in vivo, and pharmacokinetic studies. Managed and directed research teams on DST-funded projects.

Grade: Distinction

Streamlined research workflows and processes to meet tight deadlines for multiple high-priority projects, ensuring efficiency and productivity.